FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049757613> ?p ?o ?g. }

• W3049757613 endingPage "463" @default.
• W3049757613 startingPage "457" @default.
• W3049757613 abstract "Abstract Background Cognitive impairment is the most important feature of schizophrenia leading to severe functional disability. To identify pathways that improve pathophysiological neurocognition in schizophrenia is a current challenge for the development of goal-directed clinical interventions. In the present study, we investigated the effects of raloxifene (a selective estrogen modulator) and isradipine (a voltage-gated L-type calcium channel blocker) on cognitive deficits in patients with schizophrenia. Method We designed a double-blind, randomized, parallel, placebo-controlled trial. We randomized 60 patients with schizophrenia into 3 groups including isradipine 5 mg, raloxifine 60 mg, and placebo for 6 consequent weeks, all in the same shape capsules, 2 times a day, along with treatment as usual. The initial and final results of blood tests, electrocardiograms, and cognitive tests in specific domains, such as attention, processing speed, executive function, and verbal memory were evaluated. Results Our findings revealed a remarkable association between adjunctive raloxifene treatment and the alleviation of verbal memory deficits. Isradipine treatment significantly improved the verbal memory and attention dysfunction in some variables of the Stroop test, compared with the placebo. However, no effect was observed in processing speed and executive function deficits. Conclusions To the best of our knowledge, this study provides the first evidence that isradipine is a novel therapy option improving verbal memory and attention, both related to its activity in the hippocampus and the cerebellum. Further investigations are necessary to elucidate the mechanisms of action for both drugs in schizophrenia." @default.
• W3049757613 created "2020-08-21" @default.
• W3049757613 creator A5001179717 @default.
• W3049757613 creator A5013084843 @default.
• W3049757613 creator A5020166103 @default.
• W3049757613 creator A5026465019 @default.
• W3049757613 creator A5077820898 @default.
• W3049757613 creator A5082822762 @default.
• W3049757613 date "2020-08-12" @default.
• W3049757613 modified "2023-10-17" @default.
• W3049757613 title "Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia" @default.
• W3049757613 cites W1818623226 @default.
• W3049757613 cites W1970101770 @default.
• W3049757613 cites W1972336737 @default.
• W3049757613 cites W1975478015 @default.
• W3049757613 cites W1980500337 @default.
• W3049757613 cites W1981817858 @default.
• W3049757613 cites W1991137238 @default.
• W3049757613 cites W1997416098 @default.
• W3049757613 cites W2005519211 @default.
• W3049757613 cites W2013616449 @default.
• W3049757613 cites W2023959801 @default.
• W3049757613 cites W2030637641 @default.
• W3049757613 cites W2031918765 @default.
• W3049757613 cites W2041256007 @default.
• W3049757613 cites W2043709248 @default.
• W3049757613 cites W2043884992 @default.
• W3049757613 cites W2046137253 @default.
• W3049757613 cites W2048471009 @default.
• W3049757613 cites W2054547362 @default.
• W3049757613 cites W2057932313 @default.
• W3049757613 cites W2060602451 @default.
• W3049757613 cites W2067462101 @default.
• W3049757613 cites W2084588595 @default.
• W3049757613 cites W2091124131 @default.
• W3049757613 cites W2125595393 @default.
• W3049757613 cites W2128103118 @default.
• W3049757613 cites W2138773108 @default.
• W3049757613 cites W2144987307 @default.
• W3049757613 cites W2147280251 @default.
• W3049757613 cites W2155149550 @default.
• W3049757613 cites W2160603347 @default.
• W3049757613 cites W2165321423 @default.
• W3049757613 cites W2344612483 @default.
• W3049757613 cites W2497213363 @default.
• W3049757613 cites W2534820515 @default.
• W3049757613 cites W2577617665 @default.
• W3049757613 cites W2602338180 @default.
• W3049757613 cites W315929037 @default.
• W3049757613 doi "https://doi.org/10.1097/jcp.0000000000001274" @default.
• W3049757613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32796392" @default.
• W3049757613 hasPublicationYear "2020" @default.
• W3049757613 type Work @default.
• W3049757613 sameAs 3049757613 @default.
• W3049757613 citedByCount "10" @default.
• W3049757613 countsByYear W30497576132020 @default.
• W3049757613 countsByYear W30497576132021 @default.
• W3049757613 countsByYear W30497576132022 @default.
• W3049757613 countsByYear W30497576132023 @default.
• W3049757613 crossrefType "journal-article" @default.
• W3049757613 hasAuthorship W3049757613A5001179717 @default.
• W3049757613 hasAuthorship W3049757613A5013084843 @default.
• W3049757613 hasAuthorship W3049757613A5020166103 @default.
• W3049757613 hasAuthorship W3049757613A5026465019 @default.
• W3049757613 hasAuthorship W3049757613A5077820898 @default.
• W3049757613 hasAuthorship W3049757613A5082822762 @default.
• W3049757613 hasConcept C105641010 @default.
• W3049757613 hasConcept C118552586 @default.
• W3049757613 hasConcept C121608353 @default.
• W3049757613 hasConcept C126322002 @default.
• W3049757613 hasConcept C142724271 @default.
• W3049757613 hasConcept C15744967 @default.
• W3049757613 hasConcept C169900460 @default.
• W3049757613 hasConcept C170493617 @default.
• W3049757613 hasConcept C172467417 @default.
• W3049757613 hasConcept C204787440 @default.
• W3049757613 hasConcept C27081682 @default.
• W3049757613 hasConcept C2776066529 @default.
• W3049757613 hasConcept C2776412080 @default.
• W3049757613 hasConcept C2776885963 @default.
• W3049757613 hasConcept C2779889926 @default.
• W3049757613 hasConcept C530470458 @default.
• W3049757613 hasConcept C71924100 @default.
• W3049757613 hasConcept C84606932 @default.
• W3049757613 hasConceptScore W3049757613C105641010 @default.
• W3049757613 hasConceptScore W3049757613C118552586 @default.
• W3049757613 hasConceptScore W3049757613C121608353 @default.
• W3049757613 hasConceptScore W3049757613C126322002 @default.
• W3049757613 hasConceptScore W3049757613C142724271 @default.
• W3049757613 hasConceptScore W3049757613C15744967 @default.
• W3049757613 hasConceptScore W3049757613C169900460 @default.
• W3049757613 hasConceptScore W3049757613C170493617 @default.
• W3049757613 hasConceptScore W3049757613C172467417 @default.
• W3049757613 hasConceptScore W3049757613C204787440 @default.
• W3049757613 hasConceptScore W3049757613C27081682 @default.
• W3049757613 hasConceptScore W3049757613C2776066529 @default.
• W3049757613 hasConceptScore W3049757613C2776412080 @default.
• W3049757613 hasConceptScore W3049757613C2776885963 @default.

• next